IR-Med (IRME) has a profit margin of -9038.46%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2025
Trailing 12 months ending Jun 2025
IR-Med posts a profit margin of -9038.46% as of June 2025. That compares with -10214.71% in the prior-year period — up 11.5% year over year. That is below the sector sector average of 13.4%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, IR-Med's profit margin was -10214.71%. The latest reading is -9038.46% — a 11.5% year-over-year increase (period ending June 2025). Use the history and growth charts on this page for a longer lookback.
For its sector stocks, a profit margin near 13.4% is typical. IR-Med's -9038.46% is lower that level. That is roughly 67533.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
IR-Med's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -9038.46% as of June 2025; use YoY and peer views to separate noise from signal.
Context for IRME's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.4%), and (3) consistency with growth and profitability. This page covers the first two; IR-Med's other metric pages and overview cover the third.